Inactive Instrument
Eurofins-Cerep Stock Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 91.3M 103M 85.44M 77.44M 146M 9.91B 147M 1.03B 399M 5.06B 386M 378M 16.26B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 70.26M 79.15M 65.75M 59.6M 113M 7.63B 113M 790M 307M 3.89B 297M 291M 12.51B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 11/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodolphe Simonot
BRD | Director/Board Member | - | - |
Paul Ratcliffe
CHM | Chairman | - | 11/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 23/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.01% | +4,900.50% | - | - | 102M | ||
| +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | ||
| +2.76% | -1.16% | +23.05% | +83.03% | 56.95B | ||
| +0.24% | -1.37% | +4.08% | +37.22% | 48.3B | ||
| -3.76% | -0.93% | +327.90% | +691.25% | 44.51B | ||
| -2.30% | -4.06% | +25.82% | +31.42% | 43.8B | ||
| +0.31% | -1.15% | +5.50% | +112.56% | 41.12B | ||
| -0.11% | +2.30% | +9.19% | +58.68% | 31.07B | ||
| +4.51% | +8.43% | +37.27% | +34.97% | 28.97B | ||
| -1.96% | -3.38% | -9.25% | -12.85% | 24.53B | ||
| Average | +0.37% | -0.20% | +52.55% | +125.61% | 43.73B | |
| Weighted average by Cap. | +0.75% | -0.50% | +56.58% | +134.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 45.61M 37.89M 34.34M 64.86M 4.4B 65.33M 455M 177M 2.24B 171M 168M 7.21B | 41.1M 46.3M 38.46M 34.86M 65.84M 4.46B 66.31M 462M 180M 2.28B 174M 170M 7.32B |
| Net income | 7.15M 8.06M 6.7M 6.07M 11.46M 777M 11.54M 80.41M 31.28M 396M 30.25M 29.6M 1.27B | 4.78M 5.39M 4.48M 4.06M 7.66M 519M 7.72M 53.75M 20.91M 265M 20.22M 19.79M 852M |
| Net Debt | -17.25M -19.44M -16.15M -14.63M -27.64M -1.87B -27.84M -194M -75.42M -956M -72.95M -71.39M -3.07B | -21.03M -23.7M -19.68M -17.84M -33.7M -2.28B -33.94M -236M -91.95M -1.17B -88.94M -87.04M -3.75B |
Employees
-
















